BGLAF
Price
$10.42
Change
+$0.84 (+8.77%)
Updated
Jul 29 closing price
Capitalization
1.08B
Intraday BUY SELL Signals
TSNDF
Price
$0.38
Change
-$0.01 (-2.56%)
Updated
Nov 19 closing price
Capitalization
115.73M
112 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BGLAF vs TSNDF

Header iconBGLAF vs TSNDF Comparison
Open Charts BGLAF vs TSNDFBanner chart's image
Biogaia AB
Price$10.42
Change+$0.84 (+8.77%)
Volume$1K
Capitalization1.08B
TerrAscend
Price$0.38
Change-$0.01 (-2.56%)
Volume$880.79K
Capitalization115.73M
BGLAF vs TSNDF Comparison Chart in %
TSNDF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BGLAF vs. TSNDF commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGLAF is a Hold and TSNDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (BGLAF: $10.42 vs. TSNDF: $0.38)
Brand notoriety: BGLAF and TSNDF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BGLAF: 100% vs. TSNDF: 142%
Market capitalization -- BGLAF: $1.08B vs. TSNDF: $115.73M
BGLAF [@Pharmaceuticals: Generic] is valued at $1.08B. TSNDF’s [@Pharmaceuticals: Generic] market capitalization is $115.73M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGLAF’s FA Score shows that 1 FA rating(s) are green whileTSNDF’s FA Score has 0 green FA rating(s).

  • BGLAF’s FA Score: 1 green, 4 red.
  • TSNDF’s FA Score: 0 green, 5 red.
According to our system of comparison, BGLAF is a better buy in the long-term than TSNDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TSNDF’s TA Score shows that 4 TA indicator(s) are bullish.

  • TSNDF’s TA Score: 4 bullish, 6 bearish.

Price Growth

BGLAF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while TSNDF (@Pharmaceuticals: Generic) price change was -43.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.42%. For the same industry, the average monthly price growth was -7.04%, and the average quarterly price growth was +26.76%.

Reported Earning Dates

TSNDF is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.42% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BGLAF($1.08B) has a higher market cap than TSNDF($116M). BGLAF has higher P/E ratio than TSNDF: BGLAF (31.34) vs TSNDF (9.50). BGLAF YTD gains are higher at: 8.768 vs. TSNDF (-41.538). BGLAF has higher annual earnings (EBITDA): 406M vs. TSNDF (11.3M). BGLAF has more cash in the bank: 728M vs. TSNDF (27.7M). BGLAF has higher revenues than TSNDF: BGLAF (1.46B) vs TSNDF (300M).
BGLAFTSNDFBGLAF / TSNDF
Capitalization1.08B116M927%
EBITDA406M11.3M3,593%
Gain YTD8.768-41.538-21%
P/E Ratio31.349.50330%
Revenue1.46B300M487%
Total Cash728M27.7M2,628%
Total DebtN/A242M-
FUNDAMENTALS RATINGS
TSNDF: Fundamental Ratings
TSNDF
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
66
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BGLAFTSNDF
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
21%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
21%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
TSNDF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WESWX11.23N/A
N/A
TETON Westwood Equity AAA
IGLGX20.81N/A
N/A
Columbia Select Global Equity A
NMUAX11.28N/A
N/A
Neuberger Berman Multi-Cap Opp A
LAVSX16.87N/A
N/A
Lord Abbett Fundamental Equity R4
HSWRX21.25N/A
N/A
Hartford Schroders International Stk R3

BGLAF and

Correlation & Price change

A.I.dvisor tells us that BGLAF and SNOA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BGLAF and SNOA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLAF
1D Price
Change %
BGLAF100%
N/A
SNOA - BGLAF
30%
Poorly correlated
-5.38%
CTTH - BGLAF
28%
Poorly correlated
-25.09%
SHPH - BGLAF
8%
Poorly correlated
-7.58%
SDZXF - BGLAF
5%
Poorly correlated
N/A
TSNDF - BGLAF
3%
Poorly correlated
-3.48%
More

TSNDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSNDF has been closely correlated with GTBIF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TSNDF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSNDF
1D Price
Change %
TSNDF100%
-3.48%
GTBIF - TSNDF
78%
Closely correlated
-4.06%
CRLBF - TSNDF
76%
Closely correlated
-11.60%
TCNNF - TSNDF
76%
Closely correlated
-8.46%
CURLF - TSNDF
74%
Closely correlated
-2.10%
JUSHF - TSNDF
72%
Closely correlated
-5.41%
More